Jun 09, 2020 / 07:00PM GMT
Robert Patrick Jones - Goldman Sachs Group Inc., Research Division - VP
Great. Good afternoon, everyone. Welcome to the AmerisourceBergen session.
I am Bob Jones. I cover the health care services space here at Goldman. Very excited to have AmerisourceBergen with us today. I'm joined from the company by Steve Collis, Chairman, President and CEO; and Jim Cleary, EVP and CFO; and we also have Bennett Murphy, who heads up Investor Relations.
So thank you to the 3 of you for participating this year.
Steven H. Collis - AmerisourceBergen Corporation - Chairman, President & CEO
Thank you, Bob.
Questions and Answers:
Robert Patrick Jones - Goldman Sachs Group Inc., Research Division - VPSo Steve, I thought we would just jump right in. A lot of topics out there, obviously, given the current situation and how fluid things are. I thought maybe start with -- drug volumes has been a big focus area for us and for investors. And some of the data, I think, we've been tracking around the broader market